Guru Ownership Trend
Guru Analysis for Intellia Therapeutics, Inc. (NTLA)
Intellia Therapeutics, Inc. (NTLA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $215.38 M.
Top institutional holders include Catherine Wood and Renaissance Technologies (RenTech).
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $64.07 M net inflow during the quarter.
Recent activity highlights Jefferies Group who increased their stake by 200.0%. Conversely, Cliff Asness reduced exposure by 21.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Intellia Therapeutics, Inc. (NTLA)
Major holders include Catherine Wood ($285.54 M), Renaissance Technologies (RenTech) ($23.69 M), Cliff Asness ($8.34 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 19.3 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $64.07 M, with 5 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited NTLA. The total reported sell value was $2.34 M.
Yes, 1 managers opened new positions in NTLA, and 4 increased their existing holdings. The total reported buy value was $66.4 M.